| 标题 |
Abstract CT204: Phase 1a/b study of runimotamab, a HER2 x CD3 T cell-engaging bispecific antibody, administered as a single agent and in combination with trastuzumab in patients with HER2-expressing breast cancer (BC) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Research 作者:Shanu Modi; Timothy A. Yap; Tira J. Tan; Armando Santoro; Valentina Gambardella; et al 出版日期:2025-04-25 需要原始海报,不需要摘要,谢谢 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)